Abstract
Cyclic nucleotide phosphodiesterases (PDEs) have been investigated for years as targets for therapeutic intervention in a number of pathophysiological processes. Phosphodiesterase-5 (PDE5), which is highly specific for guanosine 3′-5′-cyclic-monophosphate (cGMP) at both its catalytic site and its allosteric sites, has generated particular interest because it is potently and specifically inhibited by three drugs: sildenafil (Viagra™, Pfizer), tadalafil (Cialis™, Lilly-ICOS), and vardenafil (Levitra™, Bayer GSK). Previously, we have used [3H]cGMP to directly study the interaction of cGMP with the allosteric sites of PDE5, but because cGMP binds with relatively low affinity to the catalytic site, it has been difficult to devise a binding assay for this particular binding reaction. This approach using measurement of radiolabeled ligand binding continues to allow us to more precisely define functional features of the enzyme. We now use a similar approach to study the characteristics of high-affinity [3H]inhibitor binding to the PDE5 catalytic domain. For these studies, we have prepared [3H]sildenafil and [3H]tadalafil, two structurally different competitive inhibitors of PDE5. The results demonstrate that radiolabeled ligands can be used as probes for both catalytic site and allosteric site functions of PDE5. We describe herein the methods that we have established for studying the binding of radiolabeled ligands to both types of sites on PDE5. These techniques have also been successfully applied to the study of binding of radiolabeled PDE5 inhibitors to PDE11, suggesting that these methods are applicable to the study of other PDEs, and perhaps other enzyme families.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Charbonneau, H. (1990) Structure-function relationships among cyclic nucleotide phosphodiesterases, in Cyclic Nucleotide Phosphodiesterases: Structure, Regulation, and Drug Action (Beavo, J. and Houslay, M. D., eds.), Wiley, New York, pp. 267–296.
McAllister-Lucas, L. M., Sonnenburg, W. K., Kadlecek, A., et al. (1993) The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. J. Biol. Chem. 268, 22,863–22,873.
Burns, F., Zhao, A. Z., and Beavo, J. A. (1996) Cyclic nucleotide phosphodiesterases: gene complexity, regulation by phosphorylation, and physiological implications. Adv. Pharmacol. 36, 29–48.
Francis, S. H. and Corbin, J. D. (1999) Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit. Rev. Clin. Lab. Sci. 36, 275–328.
Francis, S. H., Turko, I. V., and Corbin, J. D. (2001) Cyclic nucleotide phosphodiesterases: relating structure and function. Prog. Nucleic Acid Res. Mol. Biol. 65, 1–52.
Aravind, L. and Ponting, C. P. (1997) The GAF domain: an evolutionary link between diverse phototransducing proteins. Trends Biochem. Sci. 22, 458–459.
Francis, S. H., Lincoln, T. M., and Corbin, J. D. (1980) Characterization of a novel cGMP binding protein from rat lung. J. Biol. Chem. 255, 620–626.
Thomas, M. K., Francis, S. H., and Corbin, J. D. (1990) Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J. Biol. Chem. 265, 14,964–14,970.
Corbin, J. D., Blount, M. A., Weeks, J. L. 2nd, Beasley, A., Kuhn, K. P., Ho, Y. S., Saidi, L. F., Hurley, J. H., Kotera, J., and Francis, S. H. (2003) [3H]Sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP. Mol. Pharmacol. 63, 1364–1372.
Francis, S. H., Sekhar, K. R., Rouse, A. B., Grimes, K. A., and Corbin, J. D. (2003) Single step isolation of siblenefil from commercially available Viagra tablet. Int. J. Impot. Res. 15, 369–372.
Liu, L., Underwood, T., Li, H., Pamukcu, R., and Thompson, W. J. (2001) Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP-specific phosphodiesterase. Cell. Signal. 13, 1–7.
Corbin, J. D. and Francis, S. H. (1999) Cyclic GMP phosphodiesterase-5: target of sildenafil. J. Biol. Chem. 274, 13,729–13,732.
Francis, S. H., Thomas, M. K., and Corbin, J. D. (1990) Cyclic GMP-binding cyclic GMP-specific phosphodiesterase from lung, in Cyclic Nucleotide Phosphodiesterases: Structure, Regulation, and Drug Action (Beavo, J. and Houslay, M. D., eds.), John Wiley & Sons, New York, pp. 117–140.
Corbin, J. D. and Doskeland, S. O. (1983) Studies of two different intrachain cGMP-binding sites of cGMP-dependent protein kinase. J. Biol. Chem. 258, 11,391–11,397.
Rannels, S. R. and Corbin, J. D. (1979) Characterization of small cAMP-binding fragments of cAMP-dependent protein kinases. J. Biol. Chem. 254, 8605–8610.
Rannels, S. R. and Corbin, J. D. (1980) Two different intrachain cAMP binding sites of cAMP-dependent protein kinases. J. Biol. Chem. 255, 7085–7088.
Francis, S. H., Noblett, B. D., Todd, B. W., Wells, J. N., and Corbin, J. D. (1988) Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol. Pharmacol. 34, 506–517.
Turko, I. V., Haik, T. L., McAllister-Lucas, L. M., Burns, F., Francis, S. H., and Corbin, J. D. (1996) Identification of key amino acids in a conserved cGMP binding site of cGMP-binding phosphodiesterases: a putative NKXnD motif for cGMP binding. J. Biol. Chem. 271, 22,240–22,244.
Francis, S. H. (1985) Effectors of rat lung cGMP binding protein-phosphodiesterase. Curr. Top. Cell. Regul. 26, 247–262.
Thomas, M. K., Francis, S. H., and Corbin, J. D. (1990b) Substrate-and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP. J. Biol. Chem. 265, 14,971–14,978.
Acknowledgments
This work was supported by National Institutes of Health (NIH) research grants DK40029 and DK 58277, NIH training grant 5T32HL07752, American Heart Association (Southeast affiliate), and Pfizer.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Weeks, J.L. et al. (2005). Radiolabeled Ligand Binding to the Catalytic or Allosteric Sites of PDE5 and PDE11. In: Lugnier, C. (eds) Phosphodiesterase Methods and Protocols. Methods In Molecular Biology™, vol 307. Humana Press. https://doi.org/10.1385/1-59259-839-0:239
Download citation
DOI: https://doi.org/10.1385/1-59259-839-0:239
Publisher Name: Humana Press
Print ISBN: 978-1-58829-314-5
Online ISBN: 978-1-59259-839-7
eBook Packages: Springer Protocols